Interntional venture capital firm focused on technology and life sciences

Venture capital, early stage, technology, life sciences, Paris, London, Munich, Europe, Boston, McKinsey, Booz Allen Hamilton, Harvard Business School, Wharton, INSEAD, Sloan, Chicago GSB, MIT, Johns Hopkins, Oxford University, Cambridge University, Columbia Business School, Brown, Dartmouth,

http://www.atlasventure.com

Atlas Venture invests in tech and life sciences business in the US and Europe. It has offices in Boston, London, Munich and Paris. The firm focuses on early-stage companies. It has helped build 300+ companies in 16+ countries. Since 1995, 44 of its portfolio companies have been acquired, and 47 are public (total market cap is $15+ billion).

Tech portfolio companies include: Business Objects, Element 14, Omnia Communications, OnDisplay, RightPoint Software, SpeechWorks, Trading Dynamics and Vermeer.

Life science portfolio companies include: Actelion Pharmaceuticals (SWX: ATLN.ZUR); Alnylam (NASDAQ: ALNY); Anadys (NASDAQ: ANDS); Crucell (NASDAQ: CRXL); deCODE genetics (NASDAQ: DCGN); Exelixis (NASDAQ: EXEL); Momenta (NASDAQ: MNTA); Morphosys (Frankfurt: MOR); Nitromed (NASDAQ: NTMD); NxStage (NASDAQ: NXTM); Renovo (LSE: RNVO) and SGX Pharmaceuticals (NASDAQ: SGXP).

McKinsey, Booz Allen Hamilton, Harvard Business School, Wharton, INSEAD, Sloan, Chicago GSB, MIT, Johns Hopkins, Oxford University, Cambridge University, Columbia Business School, Brown, Dartmouth,